BRITTANY CLARK: Open Payments
NPI 1598159147 · OXFORD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 22 payments from 10 companies in 2025. Trend: 2023 $553 · 2024 $495 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Janssen Biotech, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $62 |
| Organon LLC | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Amgen Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Lilly USA, LLC | 1 | $22 |
| LEO Pharma Inc. | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $8 |
Products named: COSENTYX, TREMFYA, SKYRIZI, DUPIXENT, OTEZLA, NEMLUVIO, Rhapsido, EBGLYSS.
Industry payments across AL — which companies pay providers there.
